Subscribe to Newsletter

Small Molecules

Manufacture Small Molecules

Celebrating Small Molecule Drug Development

We look back on key interviews and opinions from individuals featured on our 2021 Power List.
Business & Regulation Advanced Medicine

The 2021 Power List is Out

We reveal The Medicine Maker 2021 Power List!
Discovery & Development Formulation

Three in One

| Thomas B “Brad” Gold

Why multilayer tablets, multiparticulates, and mini tablets could lead the way in patient-centric drug delivery.
Manufacture Small Molecules

The Only Science Is Good Science

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

Discovery & Development Drug Discovery

Sweeter Dreams

We need to open our eyes to the realities of sleep disorders.
Manufacture Facilities

A Smaller Piece of PiE

| Jonathan Rhone

Let’s reduce the impact of pharmaceutical effluent on the environment.
Business & Regulation Standards & Regulation

A Roadmap for Access

| Craig Burton

Craig Burton from the AAM says patients must be able to access generics and biosimilars.
Manufacture Small Molecules

Let’s cHAT About Drugs

| Maryam Mahdi

Does pharma really need to pay a high price when it comes to synthetic chemistry?

Discovery & Development Small Molecules

The Powder Problem

| Stephanie Vine

What happens when the same batch of powder gives different results when tested with different laser diffraction testing machines?

Manufacture Small Molecules

The Medicines Manufacturing Innovation Centre: Two Years On

| Dave Tudor

Dave Tudor gives an update on CPI’s “Grand Challenges”.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker